Aeglea BioTherapeutics Inc. Stock Price (AGLE)

Key Statistics

Open
Previous Close
Bid
Ask
Day Range -
52 Week Range -
Volume
Avg. Volume
Volume to USD
Market Cap
Beta
PE Ratio
Latest EPS
EPS TTM
Dividend
Dividend Yield
Ex-Dividend Date
Revenue TTM
Revenue per Share
Revenue per Employee
Profit Margin
Gross Profit TTM
Total Cash TTM
Total Debt TTM

Share Distribution

Shares Outstanding
Float
Short Interest
Short Ratio
Insider Ownership
Institution Ownership

Latest Headlines

CVS Health: Becoming A Healthcare PowerhouseMon, 19 Nov 2018 21:51:01 UTC via Seeking Alpha
Welltower: A 5.0%-Yielding Healthcare REIT To Own ForeverMon, 19 Nov 2018 08:38:38 UTC via Seeking Alpha
How Tap an ex-US Healthcare BoomFri, 16 Nov 2018 11:40:46 UTC via ETF Trends
CareTrust: Wait For A Drop Before Buying This 4.2%-Yielding Healthcare REITThu, 15 Nov 2018 07:43:08 UTC via Seeking Alpha
Mallinckrodt Plc (MNK) Presents at Jefferies London Healthcare Broker Conference Call (Transcript)Wed, 14 Nov 2018 23:28:08 UTC via Seeking Alpha
Geron Corporation (GERN) CEO John Scarlett Presents at Stifel 2018 Healthcare Conference Call TranscriptWed, 14 Nov 2018 19:49:15 UTC via Seeking Alpha
Walgreens Boots Alliance's (WBA) CEO Stefano Pessina Credit Suisse Healthcare Conference - TranscriptWed, 14 Nov 2018 18:50:08 UTC via Seeking Alpha
Bristol-Myers Squibb (BMY) Presents at Credit Suisse Healthcare Conference (Transcript)Wed, 14 Nov 2018 16:25:08 UTC via Seeking Alpha
Celgene Corporation (CELG) Presents at Credit Suisse 27th Annual Healthcare Conference (Transcript)Wed, 14 Nov 2018 16:00:21 UTC via Seeking Alpha
Exelixis, Inc. (EXEL) Presents at the Stifel 2018 Healthcare Conference - TranscriptTue, 13 Nov 2018 16:29:08 UTC via Seeking Alpha

Aeglea BioTherapeutics Inc. Performance

5 Day Change 1 Month Change 30 Day Change 3 Month Change 90 Day Change 6 Month Change 180 Day Change Year to Date Change 1 Year Change 2 Year Change 5 Year Change

Active Alerts for IEX:AGLE

You don't have any alerts set for IEX:AGLE.

About Aeglea BioTherapeutics Inc.

Aeglea BioTherapeutics Inc is a biopharmaceutical company committed to developing enzyme-based therapeutics in the field of amino acid metabolism, which will transform the lives of patients with inborn errors of metabolism and cancer.

CEOAnthony G. Quinn IndustryBiotechnology SectorHealthcare Websitehttp://www.aegleabio.com Issue ExchangeNASDAQ Global Market Issue TypeUnknown

Real-time AGLE to USD Trade Analysis on IEX

Market Status Open

Time Elapsed

Trades Analyzed

Last Price

Trades per Minute

Volume per Trade Average

Volume per Minute Average

Largest Trade Volume

Largest Trade Cost

Total Volume

Total Buy Volume

Total Sell Volume

Buy to Sell Volume

Buy to Sell Trades

USD per Trade Average

USD per Minute Average

USD Total Volume

Buy/Sell stats are based on the side that filled the order.

Real-time Trade History

Waiting for IEX trades to start ...

The last recorded trade was over an hour ago.